MULTIPLE VIEW MARKETING ANALYSIS OF THE RUSSIAN PLANT-BASED DRUGS MARKET

Разработка и регистрация лекарственных средств

I. A. Narkevich¹  A. V. Akamova¹  O. D. Nemyatykh¹ 

[1] St. Petersburg Chemical Pharmaceutical Academy of the Ministry of Healthcare;

关键词: plant-based drugs;    state register of medicines;    pharmaceutical market;   

DOI  :  

来源: DOAJ

【 摘 要 】

The received results show that the greatest (79%) share of plant-based drugs is presented by the domestic manufacturers. The greatest contribution (more than 13%) in structure of import supply is made by the European manufacturing enterprises. Germany (6.86%) is leading among them. The presentation of botanical drugs (31.54%) is the most frequent. One can’t help paying attention to the fraction of substances (7.67%) and semi-finished products (10.17%) in structure of import supply. The latter the indicates the dependence of domestic manufacturers on supply of raw materials from abroad. It is important to notice the share (19.87%) of medicines for digestive tract diseases and metabolic disorders treatment.

【 授权许可】

Unknown